Alzheimer’s disease (AD) is characterized by accumulation of amyloid-β plaques that further promotes microglia-mediated neuroinflammatory responses and inflammation in the brain. Emerging data are revealing the relation between gut-associated lymphoid tissue (GALT) cells and CNS, as effector cells primed in the gut might home to the brain. This study aimed to determine cell composition of GALT in 5xFAD mice, an established model for AD. Immune cells isolated from Peyer’s patches (PP) and mesenteric lymph nodes (MLN) were stained with surface and intracellular markers for T helper (Th) subpopulations, B lymphocytes and macrophages and analyzed cytofluorimetrically, while cytokine expression and production were determined by qPCR and ELISA, respectively. Inflammation was detected in GALT of 5xFAD mice with established AD pathology. Although the production of IFN-γ, IL-4, and IL-10 was comparable between the strains, lower IL-17 production was observed in PP and MLN cells. This phenomenon could not be attributed to a lower abundance of Th17 cells, or cytokines that initiate their formation or propagation (TGF-β, IL-6, and IL-23). Also, reduced IL-17 production was not a consequence of altered Il-17 mRNA transcription or deficiency of Rorγt, a key transcription factor for IL-17. However, the expression of miR-155 (a non-coding micro RNA that promotes the development of Th17 cells), was significantly lower in MLN cells of 5xFAD mice. In contrast, mice without AD neuropathology did not have inflammation in GALT or altered Th17 numbers, nor decreased IL-17 production. In conclusion, the observed changes in GALT of 5xFAD mice mirror the disease progression and might reflect inadequate immune surveillance in the gut and lead to enhanced AD pathology.
SelkoeDJ (2011) Alzheimer’s disease. Cold Spring Harb Perspect Biol3, a004457.
2.
GoldeTE (2005) The Abeta hypothesis: Leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease. Brain Pathol15, 84–87.
MarshSE, AbudEM, LakatosA, KarimzadehA, YeungST, DavtyanH, FoteGM, LauL, WeingerJG, LaneTE, InlayMA, PoonWW, Blurton-JonesM (2016) The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function. Proc Natl Acad Sci U S A113, E1316–E1325.
6.
ZhaoY, DuaP, LukiwWJ (2015) Microbial sources of amyloid and relevance to amyloidogenesis and Alzheimer’s disease. J Alzheimers Dis Parkinsonism5, 177.
7.
SyedAK, BolesBR (2014) Fold modulating function: Bacterial toxins to functional amyloids. Front Microbiol5, 401.
8.
AstiA, GioglioL (2014) Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?J Alzheimers Dis39, 169–179.
9.
FriedlandRP (2015) Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J Alzheimers Dis45, 349–362.
10.
ShoemarkDK, AllenSJ (2015) The microbiome and disease: Reviewing the links between the oral microbiome, aging, and Alzheimer’s disease. J Alzheimers Dis43, 725–738.
11.
MarquesF, SousaJC, SousaN, PalhaJA (2013) Blood-brain-barriers in aging and in Alzheimer’s disease. Mol Neurodegener8, 38.
12.
MontagneA, BarnesSR, SweeneyMD, HallidayMR, SagareAP, ZhaoZ, TogaAW, JacobsRE, LiuCY, AmezcuaL, HarringtonMG, ChuiHC, LawM, ZlokovicBV (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron85, 296–302.
13.
KwaSF, BeverleyP, SmithAL (2006) Peyer’s patches are required for the induction of rapid Th1 responses in the gut and mesenteric lymph nodes during an enteric infection. J Immunol176, 7533–7541.
14.
MowatAM (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol3, 331–341.
15.
WekerleH (2016) The gut-brain connection: Triggering of brain autoimmune disease by commensal gut bacteria. Rheumatology (Oxford)55(Suppl 2), ii68–ii75.
16.
OakleyH, ColeSL, LoganS, MausE, ShaoP, CraftJ, Guillozet-BongaartsA, OhnoM, DisterhoftJ, Van EldikL, BerryR, VassarR (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: Potential factors in amyloid plaque formation. J Neurosci26, 10129–10140.
17.
SchneiderF, BaldaufK, WetzelW, ReymannKG (2014) Behavioral and EEG changes in male 5xFAD mice. Physiol Behav135, 25–33.
18.
KimuraR, OhnoM (2009) Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis33, 229–235.
19.
IvanovII, McKenzieBS, ZhouL, TadokoroCE, LepelleyA, LafailleJJ, CuaDJ, LittmanDR (2006) The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+T helper cells. Cell126, 1121–1133.
20.
VeldhoenM, HockingRJ, AtkinsCJ, LocksleyRM, StockingerB (2006) TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity24, 179–189.
21.
LangrishCL, ChenY, BlumenscheinWM, MattsonJ, BashamB, SedgwickJD, McClanahanT, KasteleinRA, CuaDJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med201, 233–240.
22.
ChenJ, CascioJ, MageeJD, TechasintanaP, GubinMM, DahmGM, CalaluceR, YuS, AtasoyU (2013) Posttranscriptional gene regulation of IL-17 by the RNA-binding protein HuR is required for initiation of experimental autoimmune encephalomyelitis. J Immunol191, 5441–5450.
MarcheseM, CowanD, HeadE, MaD, KarimiK, AshthorpeV, KapadiaM, ZhaoH, DavisP, SakicB (2014) Autoimmune manifestations in the 3xTg-AD model of Alzheimer’s disease. J Alzheimers Dis39, 191–210.
25.
Pirker-KeesA, SchmiedC, Dal-BiancoP (2013) T-cells show increased production of cytokines and activation markers in Alzheimer’s disease. Brain Disord Ther3, 1.
26.
BrandscheidC, SchuckF, ReinhardtS, SchäferKH, PietrzikCU, GrimmM, HartmannT, SchwiertzA, EndresK (2017) Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer’s mouse model. J Alzheimers Dis56, 775–788.
27.
YoshiokaH, TakedaT, HiguchiK, OhshioG, MiyakeT, SugiyamaT, KitaT (1990) Immunohistochemical examination of Peyer’s patches in senescence-accelerated mice. Autoimmunity8, 25–35.
28.
CătanăCS, NeagoeIB, CozmaV, MagdaşC, TăbăranF, DumitraşcuDL (2015) Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World J Gastroenterol21, 5823–5830.
29.
LiangSC, TanXY, LuxenbergDP, KarimR, Dunussi-JoannopoulosK, CollinsM, FouserLA (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med203, 2271–2279.
30.
HobanAE, StillingRM, MoloneyM, MoloneyG, ShanahanRD, DinanF, CryanTG, ClarkeJF, G (2017) Microbial regulation of microRNA expression in the amygdala and prefrontal cortex. Microbiome5, 102.
31.
XuM, ZuoD, LiuX, FanH, ChenQ, DengS, ShouZ, TangQ, YangJ, NanZ, WuH, DongY, LiuY (2017) MiR-155 contributes to Th17 cells differentiation in dextran sulfate sodium (DSS)-induced colitis mice via Jarid2. Biochem Biophys Res Commun488, 6–14.
32.
YanL, HuF, YanX, WeiY, MaW, WangY, LuS, WangZ (2016) Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response. J Mol Med (Berl)94, 1063–1079.
33.
TükelC, WilsonRP, NishimoriJH, PezeshkiM, ChromyBA, BäumlerAJ (2009) Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2. Cell Host Microbe6, 45–53.
34.
McQuillanK, LynchMA, MillsKH (2010) Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells. Brain Behav Immun24, 598–607.
35.
KoutrolosM, BererK, KawakamiN, WekerleH, KrishnamoorthyG (2014) Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS. Acta Neuropathol Commun2, 163.
